K
Knight Therapeutics
Specialty pharmaceutical company focused on acquiring or in-licensing
At a glance
- Status
- Listed
- Listing
- IPO 2014
- Outcome tier
- Thoroughbred$100M+ revenue
News
Open roles
Knight Therapeutics in the Westmount ecosystem
The Knight Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Investments and acquisitions
Disclosed deals where Knight Therapeutics was the backer or acquirer, 2015–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
4 deals across Knight Therapeutics's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Knight Therapeutics's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Knight Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Knight Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

